ArticleJournal of nematology2026
Rethinking control strategies for plant-parasitic nematodes.
Article in Journal of nematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To improve management for plant-parasitic nematodes, new solutions must reflect biological realities and be guided by coherent, science-based regulations. This study addresses five areas: (1) regulatory and market hurdles that slow adaptation of biological control products despite strong safety records and scalable production; (2) microbiome-mediated soil resilience, including nematode-microbiome interactions, suppressive consortia, validated delivery systems, and diagnostics to shift soils toward durable suppression; (3) effective containment for nematodes of regulatory concern, and precise resistance bioengineering through genome editing tools that mirror natural allelic variation, thus, warranting streamlined oversight; (4) omics-enabled platforms to discover and validate RNA interference targets for nematode control in perennial crops, coupled with transgrafting; and (5) advances in affordable RNA-based biopesticides and efforts to strengthen social license. Policymakers should adopt fit-for-purpose, fast-track pathways for low-risk biological and biotechnological products, and expand support for diagnostics, core research, and field validation across production systems. Furthermore, to ensure effective implementation, ongoing communication among regulators, scientists, industry, and growers is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.